ABCL vs GOOGL · rev $12.4M vs P/E 26, rev $229.69B
Abcellera Biologics Inc (ABCL) versus Alphabet Inc Class A (GOOGL) — a side-by-side from cached financials, not a winner call.
Abcellera Biologics Inc (ABCL) is a biotechnology company listed on US.
Alphabet Inc Class A (GOOGL) is a internet content & information company listed on US. It is led by Sundar Pichai.
Latest reported ABCL revenue for 2026-06-30 was $12.4M. Net income was -$98.6M. Revenue was up 48.7% from 2026-03-31 to 2026-06-30. ABCL currently screens at market cap $1.12B.
Latest reported GOOGL revenue for 2026-06-30 was $229.69B. Net income was $174.77B. Revenue was up 23.1% from 2025-06-30 to 2026-06-30. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
ABCL currently screens at market cap $1.12B. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
Not investment advice. Open the ABCL and GOOGL stock pages for the full models.
Not investment advice.